Novo Holdings
Novo Holdings is a leading holding and investment company responsible for managing the assets and wealth of the Novo Nordisk Foundation, one of the world’s largest enterprise foundations. The company is the controlling shareholder of Novo Nordisk and Novonesis and manages a diverse investment portfolio with a long-term return perspective. Novo Holdings invests in life science companies at all stages of development and manages a broad portfolio of equities, bonds, real estate, infrastructure assets, and private equity investments. The firm is committed to improving people’s health and the sustainability of society and the planet by generating attractive long-term returns.
Novo Holdings
Tuborg Havnevej 19, 2900 Hellerup, Denmark
Portfolio
Aquafortus develops and commercializes novel and proprietary minimal energy resource recovery technologies for high total dissolved solids (TDS) waste and process streams.
#Technology
Breye Therapeutics is a clinical stage biopharmaceutical company developing novel oral therapies for retinal vascular diseases.
#Biopharmaceutical
AnaCardio is developing novel drugs to treat heart failure, based on research from Karolinska Institutet.
#Biopharmaceutical
Clever Care helps members understand the complexities of their healthcare.
#Healthcare
Allievex is building a portfolio of therapeutics for rare pediatric neurodegenerative diseases.
#Biopharmaceutical
Coave Therapeutics is pioneering the development of innovative solutions to enhance genetic medicines.
#Genetic Medicine
Key People
CEO
Partner, Planetary Health Investments
Senior Partner, Seed Investments
Partner, Seed Investments
Senior Partner, Venture Investments